Recombinant IL-7/HGFβ hybrid cytokine separates acute graft-versus-host-disease from graft-versus-tumour activity by altering donor T cell trafficking

British Journal of Haematology

Volumn 175, Issue 3, 2016, Pages 505-516

  Hu, Rong ^a,b   Liu, Yalan ^a   Song, Yinhong ^a   Su, Min ^a   Lu, Xiuling ^a   Rood, Debra ^a   Lai, Laijun ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

adhesion molecules; chemokines; graft versus host disease; graft versus tumour; T cell trafficking

Indexed keywords

RECOMBINANT INTERLEUKIN 7; SCATTER FACTOR; SCATTER FACTOR BETA; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE; HYBRID PROTEIN; INTERLEUKIN 7;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS TUMOR EFFECT; HEMATOPOIETIC SYSTEM; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ADVERSE EFFECTS; ANIMAL; CHEMOTAXIS; COMPLICATION; DISEASE MODEL; DONOR; DRUG EFFECTS; GENETICS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MORTALITY; NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CHEMOKINES; CHEMOTAXIS; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOCYTE GROWTH FACTOR; INTERLEUKIN-7; MICE; NEOPLASMS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TISSUE DONORS; TUMOR BURDEN;

EID: 84979000388     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14268     Document Type: Article

References (53)

1. Alpdogan, O., Schmaltz, C., Muriglan, S.J., Kappel, B.J., Perales, M.A., Rotolo, J.A., Halm, J.A., Rich, B.E. & van den Brink, M.R. (2001) Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood, 98, 2256–2265.
2. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nature Reviews: Molecular Cell Biology, 4, 915–925.
3. Bouazzaoui, A., Spacenko, E., Mueller, G., Miklos, S., Huber, E., Holler, E., Andreesen, R. & Hildebrandt, G.C. (2009) Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes and Immunity, 10, 687–701.
4. Bouazzaoui, A., Spacenko, E., Mueller, G., Huber, E., Schubert, T., Holler, E., Andreesen, R. & Hildebrandt, G.C. (2011) Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract. Experimental Hematology, 39, e231.
5. Bruner, R.J. & Farag, S.S. (2003) Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Seminars in Oncology, 30, 509–519.
6. Castor, M.G., Pinho, V. & Teixeira, M.M. (2012) The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics. Frontiers in Pharmacology, 3, 23.
7. Chakraverty, R., Cote, D., Buchli, J., Cotter, P., Hsu, R., Zhao, G., Sachs, T., Pitsillides, C.M., Bronson, R., Means, T., Lin, C. & Sykes, M. (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. Journal of Experimental Medicine, 203, 2021–2031.
8. Chung, B., Dudl, E., Toyama, A., Barsky, L. & Weinberg, K.I. (2008) Importance of interleukin-7 in the development of experimental graft-versus-host disease. Biology of Blood and Marrow Transplantation, 14, 16–27.
9. Coghill, J.M., Sarantopoulos, S., Moran, T.P., Murphy, W.J., Blazar, B.R. & Serody, J.S. (2011) Effector CD4 + T cells, the cytokines they generate, and GVHD: something old and something new. Blood, 117, 3268–3276.
10. Cosenza, L., Gorgun, G., Urbano, A. & Foss, F. (2002) Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cellular Signalling, 14, 317–325.
11. Duffner, U., Lu, B., Hildebrandt, G.C., Teshima, T., Williams, D.L., Reddy, P., Ordemann, R., Clouthier, S.G., Lowler, K., Liu, C., Gerard, C., Cooke, K.R. & Ferrara, J.L. (2003) Role of CXCR3-induced donor T-cell migration in acute GVHD. Experimental Hematology, 31, 897–902.
12. Dutt, S., Ermann, J., Tseng, D., Liu, Y.P., George, T.I., Fathman, C.G. & Strober, S. (2005) L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood, 106, 4009–4015.
13. El-Asady, R., Yuan, R., Liu, K., Wang, D., Gress, R.E., Lucas, P.J., Drachenberg, C.B. & Hadley, G.A. (2005) TGF-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. Journal of Experimental Medicine, 201, 1647–1657.
14. Ferrara, J.L., Levine, J.E., Reddy, P. & Holler, E. (2009) Graft-versus-host disease. Lancet, 373, 1550–1561.
15. Hildebrandt, G.C., Corrion, L.A., Olkiewicz, K.M., Lu, B., Lowler, K., Duffner, U.A., Moore, B.B., Kuziel, W.A., Liu, C. & Cooke, K.R. (2004a) Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. Journal of Immunology, 173, 2050–2059.
16. Hildebrandt, G.C., Duffner, U.A., Olkiewicz, K.M., Corrion, L.A., Willmarth, N.E., Williams, D.L., Clouthier, S.G., Hogaboam, C.M., Reddy, P.R., Moore, B.B., Kuziel, W.A., Liu, C., Yanik, G. & Cooke, K.R. (2004b) A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood, 103, 2417–2426.
17. Ichiba, T., Teshima, T., Kuick, R., Misek, D.E., Liu, C., Takada, Y., Maeda, Y., Reddy, P., Williams, D.L., Hanash, S.M. & Ferrara, J.L. (2003) Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood, 102, 763–771.
18. Jaczewska, J., Abdulreda, M.H., Yau, C.Y., Schmitt, M.M., Schubert, I., Berggren, P.O., Weber, C., Koenen, R.R., Moy, V.T. & Wojcikiewicz, E.P. (2014) TNF-alpha and IFN-gamma promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration. Journal of Leukocyte Biology, 95, 265–274.
19. Jin, J., Goldschneider, I. & Lai, L. (2011) In vivo administration of the recombinant IL-7/hepatocyte growth factor beta hybrid cytokine efficiently restores thymopoiesis and naive T cell generation in lethally irradiated mice after syngeneic bone marrow transplantation. Journal of Immunology, 186, 1915–1922.
20. Johnston, H.F., Xu, Y., Racine, J.J., Cassady, K., Ni, X., Wu, T., Chan, A., Forman, S. & Zeng, D. (2014) Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects. Biology of Blood and Marrow Transplantation, 20, 1089–1103.
21. Kim, Y.M., Sachs, T., Asavaroengchai, W., Bronson, R. & Sykes, M. (2003) Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. Journal of Clinical Investigation, 111, 659–669.
22. Kirchhofer, D., Yao, X., Peek, M., Eigenbrot, C., Lipari, M.T., Billeci, K.L., Maun, H.R., Moran, P., Santell, L., Wiesmann, C. & Lazarus, R.A. (2004) Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. Journal of Biological Chemistry, 279, 39915–39924.
23. Kolb, H.J. (2008) Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood, 112, 4371–4383.
24. Kuroiwa, T., Iwasaki, T., Imado, T., Sekiguchi, M., Fujimoto, J. & Sano, H. (2006) Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Research & Therapy, 8, R123.
25. Lai, L. & Goldschneider, I. (2001) Cutting edge: identification of a hybrid cytokine consisting of IL-7 and the beta-chain of the hepatocyte growth factor/scatter factor. Journal of Immunology, 167, 3550–3554.
26. Lai, L., Chen, F., McKenna, S. & Goldschneider, I. (1998) Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). II. PPBSF is a covalently linked heterodimer of IL-7 and a Mr 30,000 cofactor. Journal of Immunology, 160, 2280–2286.
27. Lai, L., Zeff, R.A. & Goldschneider, I. (2006) A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells. Blood, 107, 1776–1784.
28. Lai, L., Jin, J. & Goldschneider, I. (2011) In vivo antitumor activity of a recombinant IL-7/HGFbeta hybrid cytokine in mice. Cancer Research, 71, 61–67.
29. Lai, L., Zhang, M. & Goldschneider, I. (2012) Recombinant IL-7/HGFbeta efficiently induces transplantable murine hematopoietic stem cells. Journal of Clinical Investigation, 122, 3552–3562.
30. Lai, L., Zhang, M., Song, Y. & Rood, D. (2013) Recombinant IL-7/HGFbeta hybrid cytokine enhances T cell recovery in Mice following allogeneic bone marrow transplantation. PLoS ONE, 8, e82998.
31. Liang, Y., Liu, C., Djeu, J.Y., Zhong, B., Peters, T., Scharffetter-Kochanek, K., Anasetti, C. & Yu, X.Z. (2008) Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood, 111, 954–962.
32. Lokker, N.A., Mark, M.R., Luis, E.A., Bennett, G.L., Robbins, K.A., Baker, J.B. & Godowski, P.J. (1992) Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO Journal, 11, 2503–2510.
33. Lu, S.X., Holland, A.M., Na, I.K., Terwey, T.H., Alpdogan, O., Bautista, J.L., Smith, O.M., Suh, D., King, C., Kochman, A., Hubbard, V.M., Rao, U.K., Yim, N., Liu, C., Laga, A.C., Murphy, G., Jenq, R.R., Zakrzewski, J.L., Penack, O., Dykstra, L., Bampoe, K., Perez, L., Furie, B., Furie, B. & van den Brink, M.R. (2010) Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease. Journal of Immunology, 185, 1912–1919.
34. Lu, S.X., Kappel, L.W., Charbonneau-Allard, A.M., Atallah, R., Holland, A.M., Turbide, C., Hubbard, V.M., Rotolo, J.A., Smith, M., Suh, D., King, C., Rao, U.K., Yim, N., Bautista, J.L., Jenq, R.R., Penack, O., Na, I.K., Liu, C., Murphy, G., Alpdogan, O., Blumberg, R.S., Macian, F., Holmes, K.V., Beauchemin, N. & van den Brink, M.R. (2011) Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation. PLoS ONE, 6, e21611.
35. Mapara, M.Y., Leng, C., Kim, Y.M., Bronson, R., Lokshin, A., Luster, A. & Sykes, M. (2006) Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Biology of Blood and Marrow Transplantation, 12, 623–634.
36. Ostermann, G., Weber, K.S., Zernecke, A., Schroder, A. & Weber, C. (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunology, 3, 151–158.
37. Panoskaltsis-Mortari, A., Hermanson, J.R., Haddad, I.Y., Wangensteen, O.D. & Blazar, B.R. (2001) Intercellular adhesion molecule-I (ICAM-I, CD54) deficiency segregates the unique pathophysiological requirements for generating idiopathic pneumonia syndrome (IPS) versus graft-versus-host disease following allogeneic murine bone marrow transplantation. Biology of Blood and Marrow Transplantation, 7, 368–377.
38. Radojcic, V., Pletneva, M.A., Yen, H.R., Ivcevic, S., Panoskaltsis-Mortari, A., Gilliam, A.C., Drake, C.G., Blazar, B.R. & Luznik, L. (2010) STAT3 signaling in CD4 + T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model. Journal of Immunology, 184, 764–774.
39. Shlomchik, W.D. (2007) Graft-versus-host disease. Nature Reviews: Immunology, 7, 340–352.
40. Sinha, M.L., Fry, T.J., Fowler, D.H., Miller, G. & Mackall, C.L. (2002) Interleukin 7 worsens graft-versus-host disease. Blood, 100, 2642–2649.
41. Song, Y., Su, M., Panchatsharam, P., Rood, D. & Lai, L. (2015) c-Met signalling is required for efficient postnatal thymic regeneration and repair. Immunology, 144, 245–253.
42. Terwey, T.H., Kim, T.D., Kochman, A.A., Hubbard, V.M., Lu, S., Zakrzewski, J.L., Ramirez-Montagut, T., Eng, J.M., Muriglan, S.J., Heller, G., Murphy, G.F., Liu, C., Budak-Alpdogan, T., Alpdogan, O. & van den Brink, M.R. (2005) CCR2 is required for CD8-induced graft-versus-host disease. Blood, 106, 3322–3330.
43. Ueha, S., Murai, M., Yoneyama, H., Kitabatake, M., Imai, T., Shimaoka, T., Yonehara, S., Ishikawa, S. & Matsushima, K. (2007) Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. Journal of Leukocyte Biology, 81, 176–185.
44. Varona, R., Cadenas, V., Gomez, L., Martinez, A.C. & Marquez, G. (2005) CCR6 regulates CD4 + T-cell-mediated acute graft-versus-host disease responses. Blood, 106, 18–26.
45. Waldman, E., Lu, S.X., Hubbard, V.M., Kochman, A.A., Eng, J.M., Terwey, T.H., Muriglan, S.J., Kim, T.D., Heller, G., Murphy, G.F., Liu, C., Alpdogan, O. & van den Brink, M.R. (2006) Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. Blood, 107, 1703–1711.
46. Warren, E.H. & Deeg, H.J. (2013) Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies. Tissue Antigens, 81, 183–193.
47. Welniak, L.A., Blazar, B.R. & Murphy, W.J. (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annual Review of Immunology, 25, 139–170.
48. Wu, C.J. & Ritz, J. (2006) Induction of tumor immunity following allogeneic stem cell transplantation. Advances in Immunology, 90, 133–173.
49. Wysocki, C.A., Panoskaltsis-Mortari, A., Blazar, B.R. & Serody, J.S. (2005) Leukocyte migration and graft-versus-host disease. Blood, 105, 4191–4199.
50. Yan, Y., Su, M., Song, Y., Tang, Y., Tian, X.C., Rood, D. & Lai, L. (2014) Tbx1 modulates endodermal and mesodermal differentiation from mouse induced pluripotent stem cells. Stem Cells and Development, 23, 1491–1500.
51. Yi, T., Zhao, D., Lin, C.L., Zhang, C., Chen, Y., Todorov, I., LeBon, T., Kandeel, F., Forman, S. & Zeng, D. (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood, 112, 2101–2110.
52. Yi, T., Chen, Y., Wang, L., Du, G., Huang, D., Zhao, D., Johnston, H., Young, J., Todorov, I., Umetsu, D.T., Chen, L., Iwakura, Y., Kandeel, F., Forman, S. & Zeng, D. (2009) Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood, 114, 3101–3112.
53. Young, J.S., Wu, T., Chen, Y., Zhao, D., Liu, H., Yi, T., Johnston, H., Racine, J., Li, X., Wang, A., Todorov, I. & Zeng, D. (2012) Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4 + T cells that mediate autoimmune-like chronic graft-versus-host disease. Journal of Immunology, 189, 222–233.